Global Fast Food Consumption Rises the Market of Obesity Surgery Devices

ALBANY, NY, UNITED STATES - Nov 9, 2016 - Obesity can be defined as a medical condition where excess fat deposition leads to adverse health conditions. Obesity increases the chances of diseases related with heart, certain type of cancer, diabetes and osteoarthritis. Obesity has become one of the serious leading healthcare problems across the globe. It is mainly caused by increased fatty intake, reduced physical exercises and sometimes genetic inheritance. Physical exercise and diet management are the main components for the treatment of obesity whereas anti-obesity drugs are also available for fat reduction. However, sometimes diet control, exercise and medication are not effective in weight reduction in such scenarios obese people opt for surgical procedures for weight management. Obesity surgery treats obesity by removal of a portion of the stomach or reduction in size of stomach through application of gastric bands or sleeve gastrectomy.

The market for obesity surgical devices is driven by changing lifestyles, hectic work schedules, less physical exercise and increasing uptake of fast food. As estimated approximately 200 million adults are categorized as obese or overweight and is resulting in 112,000 deaths annually. This presents an enormous need for less invasive weight loss treatments. The obesity surgical devices market is segmented on the basis of various surgery devices and type of surgical procedures. Surgical devices segment comprises adjustable gastric band, intragastric balloon, clip applier, surgical staples, trocars and others. Surgical procedures section comprises restrictive procedures, malabsorptive procedures and mixed procedures.

Get the Future Market Projections of Obesity Surgery Devices at:http://bit.ly/2flL7F0

Geographically, North America dominates the markets followed by Europe and Asia. This dominance in North American region is being witnessed owing to rise in number of obese patients and mounting public awareness. However, high procedural costs are expected to restraint the market growth. On the contrary, growing demand for less invasive procedures and obesity treatment has significantly boosted the market growth. Similarly, increase in disposable income in developing nations is also a major contributing factor towards market growth.

Some of the major players engaged in obesity surgical devices market include Allergan, Inc., Covidien PLC, EnteroMedics, Inc., Cousin Biotech, Surgical IOC, PARE Surgical and other key players.